Plaintiff suffered from a severe skin ailment, lupus erythematosus. From October 1954 to January 7, 1960, at the prescription of her doctors, she took chloroquine diphosphate, a drug manufactured and distributed under the name Aralen by defendant Winthrop Laboratories, a division of Sterling Drug, Incorporated. She developed a severe limitation of vision, now diagnosed as irreversible. Attributing this impairment...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.
